Skip to content

Clinical trials

Heart Failure trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Country / region: Latvia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20082
20091
20101
20111
20121
20132
20143
20165
20173
20183
20191
20202
20221
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated4
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biotronik SE & Co. KG11
Novartis Pharmaceuticals5
Bayer2
BioVentrix2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2
American Regent, Inc.1
Amgen1
Boston Scientific Corporation1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure34
Cardiovascular Diseases5
Tachycardia5
Stroke4
Tachycardia, Ventricular4
Ventricular Fibrillation4
Diabetes Mellitus, Type 23
Myocardial Infarction3
Ventricular Remodeling3
Coronary Artery Disease2

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.